Oncology-Focused Biotech Immuneering Jumps To Wall Street With $112M IPO
Immuneering Corp (NASDAQ:IMRX) has kept a relatively low profile since launching with $17 million back in 2019. That is until…
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam’s Clinical Collaboration, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)